Một trường hợp bệnh lý mô liên kết hỗn hợp biến chứng do purpura giảm tiểu cầu huyết khối

Parker Levine S (1999) Thrombotic thrombocytopenic purpura and other forms of non-immunologic platelet destruction. In: Lee GR (ed) Wintrobe’s clinical hematology, 10th edn. vol 2. Williams &Wilkins, Baltimore, pp1612–1622 Paice EW, Snaith ML (1984) Thrombotic thrombocytopenic purpura occurring in a patient with mixed connective tissue disease. Rheumatol Int 43:141–142 ter Borg EJ, Houtman PM, Kallenberg CG, van Leeuwen MA, van Ryswyk MH (1988) Thrombocytopenia and hemolytic anemia in a patient with mixed connective tissue disease due to thrombotic thrombocytopenic purpura. J Rheumatol 15:1174–1177 Poullin P, Lefevre P, Durand JM (1999) Mixed connective tissue disease with hemolytic anemia and severe thrombocytopenia due to thrombotic thrombocytopenic purpura. Am J Hematol 61:275 Kato A, Suzuki Y, Fujigaki Y, Yamamoto T, Yonemura K, Miyajima H et al (2002) Thrombotic thrombocytopenic purpura associated with mixed connective tissue disease. Rheumatol Int 22:122–125 Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B et al (1998) von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339:1578–1584 Tsai HM, Lian EC (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339:1585–1594 Tsai HM, Rice L, Sarode R, Chow TW, Moake JL (2000) Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura. Ann Intern Med 132:794–799 Kasukawa R, Tojo T, Miyawaki S, Yoshida H, Tanimoto K, Nobunaga M et al (1987) Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC (eds) Mixed connective tissue diseases and anti-nuclear antibodies, Elsevier, Amsterdam, pp41–47 Jain R, Chartash E, Susin M, Furie R (1994) Systemic lupus erythematosus complicated by thrombotic microangiopathy. Semin Arthritis Rheum 24:173–182 Kfoury Baz EM, Mahfouz RA, Masri AF (1999) Thrombotic thrombocytopenic purpura in a patient with rheumatoid arthritis treated by plasmapheresis. Ther Apher 3:314–316 Miller A, Ryan PF, Dowling JP (1997) Vasculitis and thrombotic thrombocytopenic purpura in a patient with limited scleroderma. J Rheumatol 24:598–600 Zheng X, Chung D, Takayama TK, Majerus EM, Sadler JE, Fujikawa K (2001) Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem 276:41059–41063 Moake JL (2002) Thrombotic microangiopathies. N Engl J Med 347:589–600 Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM et al (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413:488–494 Veyradier A, Obert B, Houllier A, Meyer D, Girma JP (2001) Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood 98:1765–1772 Chemnitz J, Draube A, Scheid C, Staib P, Schulz A, Diehl V et al (2002) Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab. Am J Hematol 71:105–108 Remuzzi G, Ruggenenti P, Bertani T (1994) Thrombotic microangiopathy. In: Tisher CC, Brenner BM (eds) Renal pathology with clinical and functional correlations, 2nd edn. Lippincott, Philadelphia, pp1154–1186 Kapur A, Ballou SP, Renston JP, Luna E, Chung-Park M (1997) Recurrent acute scleroderma renal crisis complicated by thrombotic thrombocytopenic purpura. J Rheumatol 24:2469–2472